TECON BIOLOGY Co.LTD Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	3,779	3,102	2,822	3,320	3,424	2,067
Trading Asset Securities	130.8	5.52	0.47	650.94	-	20.28
Cash & Short-Term Investments	3,909	3,107	2,822	3,970	3,424	2,088
Cash Growth	6.79%	10.11%	-28.92%	15.96%	64.03%	-0.05%
Accounts Receivable	664.81	534.08	444.28	401.82	314.58	327.19
Other Receivables	300.05	396.56	425.39	464.03	437.5	173.77
Receivables	964.86	943.13	889.67	885.44	771.88	542.65
Inventory	3,068	4,594	4,554	6,042	5,251	6,020
Prepaid Expenses	-	-	-	-	5.37	2.64
Other Current Assets	1,464	1,204	695.1	1,498	1,160	2,044
Total Current Assets	9,406	9,848	8,961	12,396	10,612	10,697
Property, Plant & Equipment	6,691	6,975	7,093	6,453	6,081	4,562
Long-Term Investments	23.61	33.29	36.11	105.45	108.07	104.78
Goodwill	165.82	165.82	178.48	22.24	22.24	-
Other Intangible Assets	362.83	377.17	360.84	268.4	272.11	232.79
Long-Term Deferred Tax Assets	119.76	99.14	72.18	39.54	16.06	9.3
Long-Term Deferred Charges	27.39	26.48	31.05	30.83	26.17	122.54
Other Long-Term Assets	20.08	38.22	19.34	46.9	1.28	1.3
Total Assets	16,817	17,563	16,752	19,362	17,139	15,729
Accounts Payable	648.6	611.86	697.12	611.11	465.23	529.68
Accrued Expenses	234.81	364.43	411.89	405.67	436.52	574.08
Short-Term Debt	2,225	3,233	3,319	3,215	4,039	4,763
Current Portion of Long-Term Debt	1,010	739.8	1,366	624.37	676.7	327
Current Portion of Leases	-	126.1	122.77	102.31	64.85	-
Current Income Taxes Payable	23.45	11.68	16.83	11.23	8.27	9.09
Current Unearned Revenue	533.8	669.11	444.63	476.32	686.52	605.28
Other Current Liabilities	759.05	738.56	708.94	762.53	594.67	563.34
Total Current Liabilities	5,435	6,495	7,087	6,208	6,971	7,372
Long-Term Debt	2,161	2,057	1,225	3,133	2,059	1,399
Long-Term Leases	290.38	322.12	362.93	302.53	294.58	-
Long-Term Unearned Revenue	146.28	144.58	143.29	87.51	81.02	90.34
Long-Term Deferred Tax Liabilities	17.53	17.62	18.13	1.45	0.75	0.45
Other Long-Term Liabilities	0.09	6.42	-	-	-	-
Total Liabilities	8,049	9,043	8,837	9,733	9,406	8,862
Common Stock	1,365	1,365	1,365	1,354	1,354	1,075
Additional Paid-In Capital	3,943	3,942	3,942	3,842	3,303	1,473
Retained Earnings	1,768	1,657	1,052	2,713	2,447	3,681
Comprehensive Income & Other	93.79	51.06	51.12	5.03	-5.4	4.19
Total Common Equity	7,170	7,016	6,411	7,915	7,098	6,233
Minority Interest	1,597	1,504	1,504	1,715	634.88	634.2
Shareholders' Equity	8,767	8,520	7,915	9,630	7,733	6,868
Total Liabilities & Equity	16,817	17,563	16,752	19,362	17,139	15,729
Total Debt	5,686	6,479	6,396	7,377	7,133	6,489
Net Cash (Debt)	-1,776	-3,371	-3,574	-3,406	-3,709	-4,402
Net Cash Per Share	-1.30	-2.45	-2.65	-2.55	-3.38	-4.09
Filing Date Shares Outstanding	1,365	1,365	1,365	1,354	1,354	1,075
Total Common Shares Outstanding	1,365	1,365	1,365	1,354	1,354	1,075
Working Capital	3,971	3,353	1,874	6,188	3,641	3,325
Book Value Per Share	5.25	5.14	4.70	5.84	5.24	5.80
Tangible Book Value	6,642	6,473	5,871	7,625	6,803	6,001
Tangible Book Value Per Share	4.86	4.74	4.30	5.63	5.03	5.58
Buildings	-	5,237	4,664	4,183	3,541	2,900
Machinery	-	3,992	3,499	3,206	2,626	2,252
Construction In Progress	-	233.09	814.7	425.14	894.54	539.19

Source: S&P Global Market Intelligence. Standard template. Financial Sources.